在慢性心力衰竭患者中对心房动进行干预管理
1Department of Cardiac Electrophysiology, Ascension St. Vincent Heart Center, 8333 Naab Road #400, Indianapolis, IN 46260, USA.
Heart failure clinics
|November 12, 2023
概括
早期治疗心房动 (AF),即使使用侵入性方法,也能显著改善心力衰竭 (HF) 的结果. 对AF的快速干预为管理高频提供了更明显的好处.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭研究研究
背景情况:
- 心房动 (AF) 和心力衰竭 (HF) 具有协同作用的关系,相互恶化.
- 管理一个条件可以对另一个条件产生积极影响.
- 从历史上看,在HF患者中,保守的医疗管理是AF的首选.
研究的目的:
- 评估早期AF干预对硬HF结果的影响.
- 为了比较HF患者早期与延迟AF治疗的疗效.
主要方法:
- 审查最近的数据和临床证据.
- 在HF的背景下分析AF治疗策略的分析.
- 不同干预时间之间的结果比较.
主要成果:
- 最近的数据支持AF的早期,通常是侵入性的干预.
- 早期的AF治疗与减少硬HF结果有关.
- 在AF进展的早期介入可能会带来更大的好处.
结论:
- 对心房的早期干预在心力衰竭患者中是最受欢迎的.
- 对于AF管理的侵入性策略显示出降低HF发病率的希望.
- 及时治疗AF,包括持久形式,对于改善HF管理至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Dysrhythmias VI: Management of Dysrhythmias
16
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
16
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14


